AI-Powered Board Intelligence for a Global Commercial Team
How Emsere brought AI into the boardroom to deliver on-demand commercial intelligence.
Client
Sector
Clinical trial equipment rental and logistics
Scale
13,000+ devices, 900+ studies, 80+ countries
The decision to invest in AI
Emsere manages over 13,000 rental devices across 80+ countries, supporting 900+ clinical trials for the world's largest pharmaceutical companies. As the business continues on its strong growth journey, the commercial leadership team saw an opportunity: use AI to elevate the quality and speed of board-level reporting, and build a platform that could extend across the commercial function.
Jon Raven, Emsere's Chief Commercial Officer, chose to invest in a contained pilot timed to a live board meeting. Not a proof of concept divorced from the business; a working system that had to deliver for a board that expected precision and pace.
4
Weeks from brief to delivery
10,500+
Live CRM deals connected
700+
Signals harvested weekly
21
Slide bespoke narrative deck
The pilot: board deck automation
Leomayn built an automated intelligence system that pulls live CRM data across 10,500+ deals, combines it with signals from nine external sources, and generates a 21-slide narrative deck with supporting analysis dossier. 700+ signals are harvested weekly, scored for relevance, and synthesised into board-level commentary. The board deck creation pipeline reduces preparation from several hours to under 30 minutes per cycle, while surfacing reporting insights the team had not previously had time to assemble.
The design principle was deliberate: AI generates 100% of the graphical information translated direct from CRM source data and 50% of insightful narrative, some of which is buried to the human eye. The remaining 50% is human judgement, context that only the commercial team holds. The system does the assembly; the team provides their unique human insight and framing.
Commercial intelligence at scale
Beyond board reporting, the intelligence platform extended the commercial team's reach into sources they hadn't previously monitored at scale. Competitor acquisitions, trial registrations, and regulatory movements are now surfaced automatically, scored for relevance, and presented alongside CRM data in a single narrative.
I was highly impressed with Leomayn's combination of strategic thinking and technical delivery, and we're excited to develop further AI use-cases across the commercial team that drive our growth plan.
Jon Raven
Chief Commercial Officer, Emsere
From one deck to an AI-powered commercial system
Following the board presentation, Leomayn built a complementary automated pipeline review dossier. Each salesperson now receives their own intelligence briefing ahead of monthly pipeline reviews, combining live CRM data with the same external signals that power the board deck.
The insight captured during those reviews feeds back into the system. When the commercial team identifies context the AI missed, or corrects a narrative that needs local knowledge, those inputs sharpen the next board deck. The result is a cycle where the work of reviewing the pipeline directly improves the quality of board reporting.
Key facts
| Client | Emsere B.V. |
| Sector | Clinical trial equipment rental and logistics |
| Scale | 13,000+ rental devices, 8,000+ contracts, 900+ studies, 80+ countries |
| Project duration | 4 weeks (kickoff to board delivery) |
| Data sources | Live CRM (10,500+ deals) + 9 external intelligence feeds |
Ready to bring AI into your operations?
We help ambitious businesses build AI systems that connect live data to real decisions. Book a free discovery call to explore what this could look like for you.